Vifor Pharma AG (VIFN:SW) (GNHAY) PT Lowered to CHF120 at JPMorgan
Tweet
Share
E-mailGet Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 22 | Down: 13 | New: 31
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 22 | Down: 13 | New: 31
Trade Now!
Join SI Premium – FREE
JPMorgan analyst James Gordon lowered the price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) to CHF120.00 (from CHF130.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Antibe Therapeutics Inc (ATE:CN) (ATBPF) PT Lowered to $9 at Brookline Capital Markets
- TeamViewer (TMV:GR) (TMVWY) PT Lowered to EUR30 at Goldman Sachs
- Klepierre SA (LI:FP) (KLPEF) PT Raised to EUR20 at Goldman Sachs, Following Earnings
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
